2020
July
Public Domain by NIAID Rocky Mountain Laboratories (RML), U.S. NIH
| Two vaccination approaches against the Covid-19 virus that are under development in Oxford, UK, and in Mainz, Germany, have proved to trigger immune responses in trials with 1077 and 45 subjects, respectively. This gives justified hope that by the end of 2020 or early 2021 a vaccination against the Covid-19 virus will be available. Next more tests will be done. |